Arctoris has announced the launch of its Biophysics Centre of Excellence, a major expansion of infrastructure, expertise, and strategic partnerships…

Arctoris contributed to research advancing a fully autonomous, closed-loop molecular discovery platform, demonstrated through a case study targeting Janus kinase…

Arctoris collaborated with researchers at the University of Cambridge and King’s College London on a study demonstrating how artificial intelligence…

Arctoris was featured in Drug Discovery World (DDW) in an article exploring how the integration of end-to-end laboratory automation and…

Arctoris was featured in Forbes as part of a wider exploration of how robotics and artificial intelligence are converging to…

Arctoris was featured in Forbes following its early recognition as a trailblazer in a brand new field: the cloud lab…

What if AI could design a brand-new protein, from scratch, to tackle heart disease? That’s no longer science fiction. In…

Arctoris was featured in Drug Discovery World (DDW), one of the industry’s leading publications, following the launch of Ulysses®, our…

Arctoris was featured in First Word Pharma following the announcement of a technology partnership with Insilico Medicine, a leading AI-driven…

Arctoris was featured in a BioPharma Trend case study exploring how the Ulysses® platform combines closed-loop robotics and machine learning…

Arctoris was featured by Medicines Discovery Catapult following its collaboration with Intelligent OMICS and Medicines Discovery Catapult on a pioneering…

Arctoris is featured as a series partner in the Biology for a Better Tomorrow digital series, an initiative created with…

Arctoris was featured in Fierce Biotech following the acquisition of Eli Lilly’s Life Sciences Studio, a highly automated robotic laboratory…

Arctoris was featured in Labiotech, in an article highlighting a collaboration between the Oxford-based automation company and Swiss software firm…

Arctoris was featured in a Drug Discovery World (DDW) webinar discussing how automated experimentation platforms can accelerate drug discovery, particularly…

Arctoris was featured in Fierce Biotech following a period of significant growth, highlighting the company’s expansion and the development of…

Arctoris has been featured by Formic Ventures following the firm’s investment in the company. Formic Ventures is a venture capital…

Arctoris is featured in a video from the Royal Society of Biology’s Biology for a Better Tomorrow series exploring how…

Arctoris was featured in a Labiotech article exploring how automation technologies are transforming cancer research. The piece highlights how robotic…

Arctoris was featured in an article by Nanalyze examining the growing role of automation in life sciences laboratories. The piece…

The Therapeutic Potential of Macrocycles in Drug Discovery Structural and Conformational Properties: Macrocycles exhibit distinct physicochemical characteristics that differentiate them…

Oxford-headquartered Arctoris progresses programmes from target to hit, lead, and candidate with superior efficiency, accuracy, and confidence. Key to the company’s capabilities is the unique…